OTC Pharmaceuticals in Europe

Datamonitor's OTC Pharmaceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in Europe’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in Europe

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purpose of this report Europe comprises Belgium, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Ukraine and the United Kingdom.

[Studien Infos ausblenden]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 20
Rivalry 21
LEADING COMPANIES 22
Johnson & Johnson 22
GlaxoSmithKline Plc 27
Bayer AG 32
MARKET DISTRIBUTION 37
MARKET FORECASTS 38
Market value forecast 38
APPENDIX 39
Methodology 39
Industry associations 40
Related Datamonitor research 40
Disclaimer 42
ABOUT DATAMONITOR 43
Premium Reports 43
Summary Reports 43
Datamonitor consulting 43

LIST OF TABLES
Table 1: Europe OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: Europe OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: Europe OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: Europe OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Johnson & Johnson: key facts 22
Table 6: Johnson & Johnson: key financials ($) 24
Table 7: Johnson & Johnson: key financial ratios 25
Table 8: GlaxoSmithKline Plc: key facts 27
Table 9: GlaxoSmithKline Plc: key financials ($) 29
Table 10: GlaxoSmithKline Plc: key financials (£) 30
Table 11: GlaxoSmithKline Plc: key financial ratios 30
Table 12: Bayer AG: key facts 32
Table 13: Bayer AG: key financials ($) 35
Table 14: Bayer AG: key financials (€) 35
Table 15: Bayer AG: key financial ratios 35
Table 16: Europe OTC pharmaceuticals market distribution: % share, by value, 2009 37
Table 17: Europe OTC pharmaceuticals market value forecast: $ million, 2009–14 38

LIST OF FIGURES
Figure 1: Europe OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: Europe OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: Europe OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: Europe OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Europe, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Europe, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Europe, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Europe, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Europe, 2009 20
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Europe, 2009 21
Figure 11: Johnson & Johnson: revenues & profitability 25
Figure 12: Johnson & Johnson: assets & liabilities 26
Figure 13: GlaxoSmithKline Plc: revenues & profitability 31
Figure 14: GlaxoSmithKline Plc: assets & liabilities 31
Figure 15: Bayer AG: revenues & profitability 36
Figure 16: Bayer AG: assets & liabilities 36
Figure 17: Europe OTC pharmaceuticals market distribution: % share, by value, 2009 37
Figure 18: Europe OTC pharmaceuticals market value forecast: $ million, 2009–14 38


[Inhaltsverzeichnis ausblenden]